Read more about the article Working Together to Expand Clinical Trials in Africa

Working Together to Expand Clinical Trials in Africa

  • Post author:
  • Post category:Blog

We were honored to be part of the important discussion in a recent webinar from the African Academy of Sciences — “Strengthening the African clinical trials regulatory and ethics environment” — about extending research to areas where FHI 360/FHI Clinical has worked for decades. Participants included representatives of the AAS, Bill & Melinda Gates Foundation, World Health Organization (WHO) Regional Office for Africa, Novartis and FHI Clinical.

Continue ReadingWorking Together to Expand Clinical Trials in Africa
Read more about the article The Sooner, the Better: Planning for FDA Pre-IND Review of COVID-19 Studies

The Sooner, the Better: Planning for FDA Pre-IND Review of COVID-19 Studies

COVID-19 is a perfect example of a novel disease for which there is an urgent need for both vaccines and therapies. To help reduce the application review timelines, the FDA issued guidance for Pre-IND meeting requests in May. We summarize the recommendations and provide advice from our regulatory affairs team.

Continue ReadingThe Sooner, the Better: Planning for FDA Pre-IND Review of COVID-19 Studies
Read more about the article Sustaining Research Capacity at Sites in Limited-Resource Settings: What Can We Learn from Successful Sites?

Sustaining Research Capacity at Sites in Limited-Resource Settings: What Can We Learn from Successful Sites?

  • Post author:
  • Post category:Blog

Keeping a site functional, even in slow times, ensures it is ready as soon as there’s a need. Based on our experience with sites worldwide, we've identified the key areas on which sustainable sites proactively focus.

Continue ReadingSustaining Research Capacity at Sites in Limited-Resource Settings: What Can We Learn from Successful Sites?